NPP
2020-11-02 09:00

NPP "Melitta" has provided about 500 Russian hospitals with room disinfection units

Since the beginning of production, the Moscow Research and Production Enterprise "Melitta" has provided about 500 hospitals all over the country with pulsed ultraviolet units with xenon lamps for urgent disinfection of air and surfaces.

Meanwhile, since the beginning of 2020, more than 488 units have begun to successfully counter the spread of pandemic COVID-19 in Moscow and regional clinics, as well as abroad.

"The main advantage of our development is the combination of high efficiency and speed of treatment, proven by numerous laboratory and clinical studies conducted in accredited testing centers and clinics in Russia and abroad. In March 2020, our new generation units for decontamination of surfaces contaminated with coronavirus SARS-CoV-2 were successfully tested at the 48th Central Research Institute of the Russian Ministry of Defense," said CEO of NPP "Melitta" Yakov Goldstein.

He specified that the units developed by the company uses technology based on multi-channel impact of high-intensity pulsed ultraviolet radiation of continuous spectrum generated by xenon lamps on all vital structures of the bacterial cell. This effect is achieved through the use of a pulsed xenon lamp in the units. The technology allows for 2-5 minutes of treatment with high efficiency to completely destroy all types of bacteria, fungi and viruses in the air and on the surfaces of the premises.

About Company

Russian Scientific Production Enterprise (SPE) "Melitta" is the only full-cycle enterprise in Russia, that develops and serially produces pulsed ultraviolet systems with xenon lamps for disinfection of the air and surfaces of the premises.

Numerous Russian and foreign patents confirm the global priority of pulsed plasma-optical technology developed by the company and pulsed UV units created on its basis.

The main consumers of the company's products are medical organizations. There is also the Russian and foreign experience of successful use of UV installations in administrative, office and public buildings, hotels, production facilities.

All company products have registration certificates of Roszdravnadzor and compliance certificates of GOST R. The company's quality management system is certified to ISO standards, and products are labelled with CE, ETL marks in accordance with the requirements of European and international standards.

"We take research and evidence very seriously. We have a team of over 50 specialists of various profiles: candidates of technical sciences, doctors of medical sciences, microbiologists and disinfectionists. This is why we are different from our competitors: we see the needs of medical market from inside", - said Yakov Goldstein, General Director of NPP "Melitta".

Company history

In 1991 specialists of Melitta in cooperation with the Institute of Power Engineering of Bauman Moscow State Technical University developed the world's first samples of pulsed ultraviolet devices with xenon lamps. In 2003, the technology was finalized and registered by Melitta in the Ministry of Health.

Since 2005, the company started mass production of various models of Alfa series units (mobile, portable and stationary) and their introduction into practical health care and space medicine. The efficiency of the technology is proven in numerous studies performed on the basis of the leading Russian and foreign accredited laboratory centers and clinics.

Since 2015, the company has taken an active part in the ExoMars international space program to eliminate the threat of Mars contamination by bacterial spores capable of surviving in the extreme conditions of outer space.

Since 2018, the company has been mass-producing a new generation of pulsed UV units of the "Alpha" series, and has also started to independently introduce export models of the "Yanex" series abroad.

At present more than 3 000 units are successfully operated in more than 500 medical organizations of Russia, and export models of "Yanex" series units are working in clinics in South Africa, Italy, Ireland, Great Britain, Mexico, Romania, Israel and Kazakhstan.

Partnership and membership in associations

NPP "Melitta" is a member of the "Moscow Chamber of Commerce and Industry" Union, a participant of the Moscow government program "Made in Moscow", Innovation Territorial Cluster "Zelenograd", Moscow Innovation Cluster, a participant of Moscow Export Center and Russian Export Center projects, a partner of Moscow Department of Entrepreneurship and Innovation Development, a member of the public organization Business Russia. In addition to supporting the domestic market, the company constantly participates in key medical forums and exhibitions around the world.